FTC Steps Into FDA’s ‘Ministerial’ Gap, Seeks Delisting Of REMS Patent

 
• By Brenda Sandburg
Orange patent
FTC files brief in suit over listing of patents in FDA's Orange Book • Source: Shutterstock

More from Legal & IP

More from Generics Bulletin